Tcm Group As · OMXCOP:TCM

Tcm Group As — Q3 2024 Earnings Presentation

10 slides from Tcm Group As's earnings presentation, Nov 22, 2024

  1. Slide 1: TCM Group A/S Interim Report July - September 2024

    TCM Group A/S Interim Report July - September 2024 November 22, 2024

  2. Slide 2: Business update Q3 2024

    Business update Q3 2024  Organic revenue growth of 7% supported by strong growth in B2C sales.  Revenue in Q3 of DKK 278 million vs. DKK 259 million last year.  Total order-intake in Denmark down by 5% due to the slowdown in B2B-projects.  Gross margin improvement on LY Q3, up from 17.7% to 20.3

  3. Slide 3: The B2C market is in good shape while the B2B market is challenged

    The B2C market is in good shape while the B2B market is challenged  Order intake from B2C slowed down during the summer months, largely flat on Q3 last year.  B2C revenue up 20% y-o-y in Q3.  B2C orders generally have a higher average sales prices and thus more profitable than B2B orders (on aver

  4. Slide 4: Q3: Organic sales growth and improved earnings

    Q3: Organic sales growth and improved earnings Revenue 278 mDKK (259 mDKK) Cash conversion 7% 120.6% Organic growth (13.2%) y-o-y NWC ratio Adjusted EBIT -0.1% 17 mDKK (3.8%) (3 mDKK) Adjusted EBIT margin 6.0% (1.0%) 4

  5. Slide 5: Q3: Revenue development

    Q3: Revenue development Revenue development Q3 comments:  Organic revenue increase of 7.4% despite a decline in B2B-sales.  Organic revenue growth in Denmark of 10.5%.  Revenue in Norway decreased by 4.4% under very difficult trading conditions.  Increasing share of lower-margin third-party sale

  6. Slide 6: Income statement highlights

    Income statement highlights Gross margin EBIT and EBIT margin Q3 comments:  Gross margin significantly improved: 20.3% up from 17.7% in Q3 LY  Gross margin normalization after last years downward correction.  Sales mix as more profitable B2C sales took a bigger share of sales.  Increasing share

  7. Slide 7: Net working capital and NIBD

    Net working capital and NIBD Net working capital Net interest-bearing debt Q3 comments:  NWC ratio -0.1% compared to 3.8% LY  Inventories as percentage of sales reduced from 36% to 32%.  NIBD reduced from DKK 417m to DKK 329m.  Leverage ratio of 2.78 (5.21 Q3 LY), well within covenants 7

  8. Slide 8: Cash flow

    Cash flow Free cash-flow Q3 comments:  Free cash flow was DKK 6m compared to DKK 18m in Q3 LY.  Capex ratio was 0.6% of revenue compared to 1.8% in Q3 LY.  Cash conversion (LTM) of 121%, supported by the positive development in NWC in recent quarters. 8

  9. Slide 9: Financial outlook 2024

    Financial outlook 2024 Financial outlook:  Net revenue: DKK 1,150-1,200 million (previously DKK 1,125-1,200 million)  Adjusted EBIT: DKK 75-90 million (previously DKK 70-90 million)  Adjusted EBIT includes an expected positive effect from adjustment of contingent payment obligations related to th

  10. Slide 10: Q&A

    Q&A

TCM Group — Q3 2024 Earnings Presentation on 6ix